Shandong Weigao Medical Polymer Operating Cash Flow Per Share 2012-2024 | SHWGF
Shandong Weigao Medical Polymer operating cash flow per share from 2012 to 2024. Operating cash flow per share can be defined as a measure of financial performance calculated as operating cash flow, expressed on a per share basis
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $3.459B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||